We studied field performance of containerised Pinus sylvestris and Picea abies seedlings of different provenances. Shoot height, needle chemical composition, root collar diameter, root mycorrhization and mycorrhizal species composition were evaluated after four growing seasons following outplanting. The results showed that in general spruce had better survival than pine. Ectomycorrhizas on spruce were dominated by Wilcoxina, Amphinema and Tylospora, while on pine — by Suillus and Thelephora species. Spruce and pine showing best growth rates were colonised by ectomycorrhizal fungus Amphinema sp. In conclusion, the results demonstrated that forest nursery practices as well as provenance can significantly impact survival, growth and mycorrhization of the containerised pine and spruce seedlings.
The clinical effects on knee osteoarthritis (OA) symptoms and tissue structure were evaluated after bone marrow-derived mononuclear cell intraarticular injection. A group of 32 patients with 34 knee joints in stage II–III osteoarthritis were treated by intraarticular injection of mononuclear cell suspension. Clinical results were obtained by KOOS (Knee Osteoarthritis Outcome Score) and KSS (Knee Society Score) scores during a 12 months follow-up period. Radiological evaluation was performed using magnetic resonance imaging. A comparison with a control group of 28 patients treated with routinely used three hyaluronic acid intra-articular injections was made. No adverse effects were observed after the bone marrow derived mononuclear cells (BM-MNC) injection. At the end point of the follow up all score results had improved, compared to those at to the starting point. 65% of patients maintained minimal perceptible clinical improvement of the score results. The Whole Organ Magnetic Resonance Imaging Score showed improvement from 44.31 to 42.93 points (p < 0.05) during a 6–7 month period. Comparing score results to the control group, a statistically significant (p < 0.05) improvement in the KOOS pain subscale score at the 6 and 12 months was observed in the mononuclear cell group. BM-MNC injection leads to a decrease of knee OA symptoms and slows changes in structure of the degenerative joint tissue.